Company intelligence / Profile preview
Aponia Laboratories
Greenwich, Connecticut, United Statesaponialabs.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Aponia Laboratories developed topical prescription and over-the-counter pain relief products based on non-steroidal anti-inflammatory drugs, primarily targeting arthritis and acute pain. Their lead product utilized dexibuprofen as the active ingredient, aiming for immediate relief with reduced side effects. The company established a robust intellectual property portfolio but is now dissolved and has no ongoing clinical trials or commercial products.
- Therapeutic areas
- RheumatologyImmunologyNeurology
- Modalities
- Small moleculeNon-steroidal anti-inflammatory drug (NSAID)
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Aponia Laboratories.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aponia Laboratories.